High expression of PDE4D correlates with poor prognosis and clinical progression in pancreaticductal adenocarcinoma

Conclusions: Our study reveals that PDE4D up-regulated in PDAC was closely associated with poor prognosis of PDAC patients and multiple aggressive clinicopathological characteristics. PDE4D could be a useful prognostic biomarker and therapeutic target for PDAC.

Source: Journal of Cancer - December 14, 2019 Category: Cancer & Oncology Authors: Fude Liu, Jieyi Ma, Kebing Wang, Zhi Li, Qingping Jiang, Hui Chen, Wen Li, Jintang Xia Tags: Research Paper Source Type: research